SCHEMBL1201145

SCHEMBL1201145

CC[Si](CC)(CC)Oc1ccccc1C=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.55
HPGD P15428 1/20 0.55
HTT P42858 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
NPSR1 Q6W5P4 1/20 0.49
LMNA P02545 3/20 0.47
KMT2A Q03164 2/20 0.47
GAA P10253 1/20 0.47
PTGDR2 Q9Y5Y4 1/20 0.46
CYP1A2 P05177 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP2C19 P33261 1/20 0.46
SRC P12931 2/20 0.44
MEN1 O00255 1/20 0.43
THRB P10828 1/20 0.43
BLM P54132 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
TSHR P16473 1/20 0.41
TLR2 O60603 1/20 0.41
ERN1 O75460 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1200344 0.86 ALDH1A1 (0.52) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL5888602 0.81 ALDH1A1 (0.36) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL1200637 0.79 ALDH1A1 (0.55) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL13893746 0.75 ALDH1A1 (0.34) ALDH1A1HPGDHTTSMN1; SMN2LMNA
SCHEMBL7187320 0.75 ALDH1A1 (0.47) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL31401930 0.75 ALDH1A1 (0.73) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL535646 0.75 ALDH1A1 (0.73) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL31282555 0.74 ALDH1A1 (0.50) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL4599831 0.74 ALDH1A1 (0.50) ALDH1A1HPGDHTTSMN1; SMN2NPSR1
SCHEMBL812635 0.73 ALDH1A1 (0.77) ALDH1A1HPGDHTTSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2154123-B1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL CO (JP) 2013-10-23 EP disclosed
US-8309753-B2 Method for producing optically active cyanohydrin compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2012-11-13 US disclosed
US-20110034718-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2011-02-10 US disclosed
EP-2264005-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-12-22 EP disclosed
US-7851659-B2 Method for producing benzaldehyde compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-12-14 US disclosed
US-20100234645-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-09-16 US disclosed
EP-2154123-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND Sumitomo Chemical Company, Limited (JP) 2010-02-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100234645-A1 METHOD FOR PRODUCING BENZALDEHYDE COMPOUND NQO1, NQO2, NDUFC2 ALDH1A1 94/4885HPGD 564/4885HTT 2486/4885
US-20110034718-A1 METHOD FOR PRODUCING OPTICALLY ACTIVE CYANOHYDRIN COMPOUND CBR3, ACSL3, CCNL2 ALDH1A1 129/4885HPGD 1408/4885HTT 3186/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.